Sunday, March 01, 2020 7:15:49 PM
Longfellow95,
Thank you for the information. I didn’t know that some of the 17 acres is designated Green Belt.
Re: post 268512
I believe it was here: https://www.mill-lane-sawston.co.uk/about-us/ (now dead link)
Advent Bioservices; 81,000 sq/ft (Announced Jan.2019)
https://www.linkedin.com/posts/kwokpang_cartcells-celltherapy-genetherapy-activity-6580448941547024386-bnzb/
Advent Bioservices: 1 year ago = 7 employees.
today = at least 21 employees ( at least 6 hired this year)
Thank you for the information. I didn’t know that some of the 17 acres is designated Green Belt.
Re: post 268512
Advents plan is 450 employees, and to supply Europe for GBM, it would have to be bigger than Cognate to serve that purpose. (Flipper)
Where did you see that?
Why stop at 450?
I believe it was here: https://www.mill-lane-sawston.co.uk/about-us/ (now dead link)
Even if they brought into service a third suite that would be 6000 sq ft.
Cognate is 80,000 sq ft.
Advent Bioservices; 81,000 sq/ft (Announced Jan.2019)
https://www.linkedin.com/posts/kwokpang_cartcells-celltherapy-genetherapy-activity-6580448941547024386-bnzb/
Advent Bioservices: 1 year ago = 7 employees.
today = at least 21 employees ( at least 6 hired this year)
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
